Hello and welcome to the details of Benefits of AstraZeneca vaccine outweigh risks, says Swedish Medical Products Agency and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
STOCKHOLM, April 7 — The Swedish Medical Products Agency said today the benefits of the AstraZeneca Covid-19 vaccine outweighed the risks after the EU drug regulator said it had found a possible link between the shot and rare blood clots.
Sweden paused the use of the AstraZeneca vaccine in March after reports of rare but serious blood clots among people vaccinated with the AstraZeneca shot. Sweden later resumed use for people over 65.
“We stand behind this conclusion, that the benefits outweigh the risks,” Ulla Wandel Liminga at the Medical Products Agency told a news conference.
The EU drug regulator said today that the vaccine had possible links with very rare cases of unusual blood clots with low blood platelet counts, but it reiterated that its advantages outweighed its risks and recommended no age or gender limits for its use. — Reuters
These were the details of the news Benefits of AstraZeneca vaccine outweigh risks, says Swedish Medical Products Agency for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.